Jenna L Strelo, NP
Nurse Practitioner · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Office
- 1
- Since medical school
- 15 years
- Columbia University College of Physicians and Surgeons, 2011
Offices
1 location · UCSF Medical Group Business Services · 1,533 clinicians in this group
Hospitals listed: Adventist Health Ukiah Valley · UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Jenna L Strelo’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence G20700 · Cancelled
Licence status: Cancelled · since 1971 · Saint Louis University School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health Ukiah ValleyUkiah, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 66% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 7.9 (5.8 to 10.5) · 253 cases, Jan 2024 – Dec 2024
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Adventist Health Ukiah Valley
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 4 the same, 0 worse of 4 measures. Readmissions: 0 better, 8 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.9 (5.8 to 10.5) · 253 cases | Worse | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.92 (0 to 1.95) · 319 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.51 to 1.32) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.3 · 38 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.9 · 137 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.4 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.3 · 74 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 647 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,093 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.08 to 0.51) · 2,081 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.64 (2.23 to 7.05) · 328 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 99 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.45 (0.79 to 4.11) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.96 (0 to 15.74) · 117 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.32 (2.24 to 10.4) · 103 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.18 to 3.17) · 119 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.29 (0 to 1.2) · 1,614 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.891 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.607 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.396 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 114 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -0.9 · 171 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 6.5 · 270 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 234 cases | None | Jul 2023 – Jun 2025 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.4 (8 to 13.6) · 253 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 37 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.4 to 17.4) · 1,320 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 361 cases | No different | Jan 2024 – Dec 2024 |
What patients said (341 patients answered, 15% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 62% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 33% |
| "YES", patients would definitely recommend the hospital | 66% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$10,538
Medicare paid this office $10,538 for 67 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Destruction of skin growth, 1-14 growths | 23 | $2,187 | $59 |
| Return visit (30+ min) | 20 | $1,724 | $69 |
| Short return visit (20+ min) | 26 | $1,717 | $50 |
| Destruction of precancer skin growth, 15 or more growths | 11 | $1,608 | $77 |
| Destruction of precancer skin growth, 1 growth | 30 | $1,478 | $33 |
See all 6 services
| Destruction of skin growth, 1-14 growths | 23 | $2,187 | $59 |
| Return visit (30+ min) | 20 | $1,724 | $69 |
| Short return visit (20+ min) | 26 | $1,717 | $50 |
| Destruction of precancer skin growth, 15 or more growths | 11 | $1,608 | $77 |
| Destruction of precancer skin growth, 1 growth | 30 | $1,478 | $33 |
| Destruction of precancer skin growth, 2-14 growths | 25 | $65 | $1 |
Procedures year by year
| Procedure | 2015 | 2016 | 2019 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | – | – | – | – | 117 | 44 |
| Destruction of precancer skin growth, 1 growth | – | – | – | – | 26 | 45 |
| Destruction of skin growth, 1-14 growths | – | – | – | – | 19 | 37 |
| Destruction of precancer skin growth, 15 or more growths | – | – | – | – | – | 21 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
67 Original Medicare patients in 2024. Average age 74 · Women 48% · Health risk score 2.96. Sicker patients than 9 in 10 peers; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 70% · Cancer 39% · Coronary heart disease 33% · Heart failure 21% · Atrial fibrillation 21% · Chronic kidney disease 19%.
The office billed $57,041, Medicare allowed $13,891 and paid $10,538; for 254 services of 16 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 67 | 254 | 74 | 2.96 | $57,041 | $10,538 |
| 2023 | 54 | 244 | 75 | 2.48 | $41,793 | $7,190 |
| 2022 | 20 | 55 | 74 | 2.81 | $11,282 | $2,223 |
| 2019 | 25 | 38 | 73 | 2.87 | $22,346 | $4,336 |
| 2016 | 21 | 41 | 73 | 1.79 | $5,369 | $1,515 |
| 2015 | 15 | 19 | 70 | 1.74 | $3,244 | $934 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Return visit (30+ min) | 14 | $1,305 | $72 |
| Destruction of skin growth, 1-14 growths | 12 | $1,111 | $58 |
| Destruction of precancer skin growth, 1 growth | 19 | $875 | $34 |
| Short return visit (20+ min) | 13 | $674 | $52 |
| Destruction of precancer skin growth, 2-14 growths | 15 | $181 | $2 |
2019: 1 service
| Application of light by qualified health care professional to destroy precancer skin growth | 12 | $2,138 | $153 |
2016: 1 service
| Return visit (30+ min) | 13 | $774 | $55 |
Drugs they prescribed that Part D paid
$19,792
Pharmacies billed $19,792 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 152) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
144 generic and fewer than 11 brand-name prescriptions · $19,792 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Clobetasol Propionate | 12 | $925 | $77 |
| Mupirocin | 22 | $408 | $19 |
| Ciclopirox | 14 | $347 | $25 |
| Triamcinolone Acetonide | 12 | $308 | $26 |
| Ketoconazole | 15 | $169 | $11 |
See all 6 drugs
| Clobetasol Propionate | 12 | $925 | $77 |
| Mupirocin | 22 | $408 | $19 |
| Ciclopirox | 14 | $347 | $25 |
| Triamcinolone Acetonide | 12 | $308 | $26 |
| Ketoconazole | 15 | $169 | $11 |
| Hydrocortisone | 11 | $142 | $13 |
Year by year
| 2024 | 152 | 54 | 0% (0) | None | $19,792 |
| 2023 | 70 | 32 | 0% (0) | None | $3,166 |
| 2022 | 79 | 40 | 0% (0) | None | $7,146 |
| 2021 | 83 | 38 | 0% (0) | None | $6,156 |
| 2020 | 139 | 58 | 0% (0) | 9% | $9,563 |
| 2019 | 71 | 39 | 0% (0) | None | $4,542 |
| 2018 | 46 | 34 | 0% (0) | None | $4,627 |
| 2017 | 102 | 54 | 0% (0) | None | $8,651 |
| 2016 | 188 | 71 | 0% (0) | 18% | $266,164 |
| 2015 | 173 | 52 | 0% (0) | 20% | $106,610 |
| 2014 | 174 | 49 | None | 17% | $60,199 |
| 2013 | 131 | 43 | 0% (0) | 15% | $28,877 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Ketoconazole | 11 | $238 | $22 |
2022: 1 drug
| Triamcinolone Acetonide | 12 | $3,358 | $280 |
2021: 1 drug
| Triamcinolone Acetonide | 13 | $252 | $19 |
2020: 4 drugs
| Ketoconazole | 12 | $488 | $41 |
| Triamcinolone Acetonide | 12 | $295 | $25 |
| Mupirocin | 25 | $229 | $9 |
| Hydroxyzine | 14 | $209 | $15 |
2019: 1 drug
| Triamcinolone Acetonide | 13 | $247 | $19 |
2017: 2 drugs
| Mupirocin | 13 | $312 | $24 |
| Triamcinolone Acetonide | 15 | $238 | $16 |
2016: 3 drugs
| Clobetasol Propionate | 24 | $4,909 | $205 |
| Triamcinolone Acetonide | 25 | $652 | $26 |
| Mupirocin | 25 | $344 | $14 |
2015: 3 drugs
| Clobetasol Propionate | 39 | $14,728 | $378 |
| Methotrexate | 15 | $1,121 | $75 |
| Triamcinolone Acetonide | 18 | $418 | $23 |
2014: 4 drugs
| Valchlor | 14 | $47,841 | $3,417 |
| Clobetasol Propionate | 36 | $5,685 | $158 |
| Triamcinolone Acetonide | 22 | $538 | $24 |
| Sulfamethoxazole-Trimethoprim | 12 | $138 | $12 |
2013: 4 drugs
| Clobetasol Propionate | 24 | $604 | $25 |
| Triamcinolone Acetonide | 13 | $334 | $26 |
| Hydroxyzine | 11 | $295 | $27 |
| Mupirocin | 13 | $199 | $15 |
Money from drug and device companies
$441 in 2025
| 2025 | 6 | 10 | None | $441 |
| 2021 | 1 | 3 | None | $66 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Biotech | Rybrevant | $231 | 3 payments
|
| Teleflex | Barrigel | $78 | 2 payments
|
| AngioDynamics | Nanoknife | $52 | 2 payments
|
| Pfizer | Xtandi | $45 | 1 payment
|
| Caris MPI | Mi Cancer Seek | $18 | 1 payment
|
| Ferring Pharmaceuticals | Adstiladrin | $17 | 1 payment
|
See all 10 published payments
| AngioDynamics | Meals · 2025-12-05 | Nanoknife | $28 |
| Pfizer | Meals · 2025-10-13 | Xtandi | $45 |
| Caris MPI | Meals · 2025-09-16 | Mi Cancer Seek | $18 |
| AngioDynamics | Meals · 2025-09-10 | Nanoknife | $24 |
| Janssen Biotech | Meals · 2025-09-09 | Erleada | $34 |
| Janssen Biotech | Education · 2025-07-21 | Erleada | $68 |
| Teleflex | Meals · 2025-04-09 | Barrigel | $38 |
| Janssen Biotech | Meals · 2025-03-27 | Rybrevant | $129 |
| Ferring Pharmaceuticals | Meals · 2025-02-18 | Adstiladrin | $17 |
| Teleflex | Meals · 2025-01-23 | Barrigel | $40 |
See earlier years (2021)
2021: $66
| Pharmacyclics LLC An AbbVie | Imbruvica | $66 | 3 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1386943256
- Licence
- CA 20700, NY 336601California G20700: Cancelled
- Trained
- Columbia University College of Physicians and Surgeons, 2011 · 15 years ago
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X); Nurse practitioner (363L00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2011-03-17
- NPI last updated
- 2025-06-05
- NPI record certified
- 2025-06-05
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305